Kineret Market Report 2026

Kineret Market Overview

• The Kineret market growth in the historic period has been driven by unmet needs in inflammatory disorders, clinical success of il 1 blockade • Market expansion is supported by growing recognition of autoinflammatory diseases, expansion into new indications • Growth Driver: Rising Prevalence Of Autoimmune Diseases Driving Growth In The Market • Market Trend: Strategic Partnerships Driving Innovation And Growth In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Kineret Market?

Kineret is the brand name for anakinra, a prescription medication primarily used to treat certain inflammatory conditions. It is a recombinant form of the human interleukin-1 receptor antagonist (IL-1Ra), which works by inhibiting the activity of interleukin-1 (IL-1), a protein involved in inflammatory and immune responses. The main indication types of kineret are treatment of rheumatoid arthritis, treatment of Still's disease, treatment of cryopyrin-associated periodic syndromes, and treatment of neonatal-onset multisystem inflammatory disease (NOMIDN). Rheumatoid arthritis is an autoimmune disorder that causes chronic inflammation, pain, and swelling in the joints, leading to potential joint damage and disability. Formulations include injectable formulations (subcutaneous) and pre-filled syringes or auto-injectors, and patient demographics are pediatric patients, adult patients, and geriatric patients. Different distribution channels are hospital pharmacies, retail pharmacies, online pharmacies, and wholesalers and distributors, and it is used by various end users such as hospitals, specialty clinics, outpatient treatment centers, and home healthcare providers.

What Is The Kineret Market Growth Forecast?

The growth in the forecast period can be attributed to growing recognition of autoinflammatory diseases, expansion into new indications, increasing pediatric biologic use, improved access to specialty care, ongoing biologic innovation. Major trends in the forecast period include expansion of il 1 inhibitor use, rising treatment of autoinflammatory diseases, growth in pediatric inflammatory care, preference for targeted cytokine therapies, increased use in rare inflammatory syndromes.

Global Kineret Market Segmentation

1) By Indication: Treatment Of Rheumatoid Arthritis, Treatment Of Still's Disease, Treatment Of Cryopyrin-Associated Periodic Syndromes, Treatment Of Neonatal-Onset Multisystem Inflammatory Disease (NOMIDN) 2) By Formulation: Injectable formulation, Pre-filled Syringes Or Auto-injectors 3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Wholesalers And Distributors 5) By End-User: Hospitals, Specialty Clinics, Outpatient Treatment Centers, Home Healthcare Providers

What Are The Drivers Of The Kineret Market?

The increasing prevalence of autoimmune diseases is expected to propel the growth of the kineret market going forward. Autoimmune diseases refer to a group of disorders where the body’s immune system mistakenly attacks its cells, tissues, and organs, treating them as foreign invaders. The increasing prevalence of autoimmune diseases can be attributed to a combination of genetic, environmental, and lifestyle factors. Kineret is a medication that can be useful in treating autoimmune diseases, particularly in managing conditions that involve excessive inflammation due to the immune system attacking the body’s tissues. For instance, in May 2023, according to the National Institute for Health and Care Research (NIHR), a UK-based health and care research organization, a study of 22 million people reveals that autoimmune disorders now impact approximately one in ten individuals, with 19 autoimmune diseases affecting around 10% of the population, 13% of women, and 7% of men. Therefore, the increasing prevalence of autoimmune diseases is driving the growth of the kineret industry. The rising prevalence of inflammatory diseases is expected to propel the growth of the kineret market going forward. Inflammatory diseases refer to a group of conditions characterized by the immune system's abnormal response, leading to chronic or acute inflammation in tissues or organs. The rising prevalence of inflammatory diseases can be attributed to several factors, including an aging population, increased exposure to environmental pollution, and lifestyle factors such as poor diet, sedentary behavior, and smoking. Kineret (anakinra) helps manage inflammatory diseases by inhibiting interleukin-1 (IL-1), a crucial protein that drives the inflammatory response. For instance, in 2023, according to Crohn's and Colitis Canada, a Canada-based non-profit organization, the number of people in Canada with IBD is increasing rapidly, from 322,600 in 2023 (0.8% of the population) to 470,000 in 2035 (1.1% of the population). In 2023, 11,000 people will be diagnosed (1 every 48 minutes), and by 2035, this will rise to 14,000 (1 every 38 minutes). Therefore, the rising prevalence of inflammatory diseases is driving the growth of the kineret industry.

Key Players In The Global Kineret Market

Major companies operating in the kineret market are Sobi (Swedish Orphan Biovitrum AB)

Global Kineret Market Trends and Insights

The key trend in the kineret market is the adoption of strategic partnerships to develop innovative Kineret-based products and gain a competitive advantage. These partnerships enable companies in the Kineret market to pool resources and expertise, strengthen research and development efforts, broaden market presence, and expedite product commercialization, fostering innovation and growth within the industry. For instance, in May 2024, Swedish Orphan Biovitrum AB, a Sweden-based biopharmaceutical company, partnered with Handok Inc., a South Korea-based pharmaceutical company, to launch Kineret (anakinra) in South Korea. This collaboration combines Handok's local expertise with Sobi's global biopharmaceutical capabilities, particularly in the realm of rare diseases.

Regional Insights

North America was the largest region in the kineret market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Kineret Market?

The kineret market consists of sales of pre-filled syringes and auto-injectors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Kineret Market Report 2026?

The kineret market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the kineret industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.